drugset / Trial / NCT04190966

Smoking Cessation in the Surgical Pathway Before Major Lung Surgery

NCT04190966

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a feasibility study of a personalised, integrated smoking cessation in the surgical pathway in patients undergoing major elective thoracic surgery when compared to usual care of standard community/hospital based NHS smoking cessation. Half the patients will receive the intervention and half the patients will receive usual care.

Timeline

Start
2020-01-31
Primary completion
2021-07-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown
Subject Varenicline Small molecule

Indications

No indication recorded.